Sign up to save your podcasts
Or
Share NRG-GU006 at the 2025 ASTRO Clinical Trials Session
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
NRG-GU006 at the 2025 ASTRO Clinical Trials Session
Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.
View all episodes
By NRG Oncology
5
1010 ratings
Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.
More shows like The NRG Oncology Podcast
View all
Planet Money
30,660 Listeners
Hidden Brain
43,758 Listeners
The Daily
112,597 Listeners
Up First from NPR
56,450 Listeners
The Indicator from Planet Money
9,505 Listeners
Fiction - Comedy Fiction
6,446 Listeners
QuadShot News Podcast
61 Listeners
Morning Brew Daily
2,998 Listeners
The Prof G Pod with Scott Galloway
5,515 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,911 Listeners
The Ezra Klein Show
16,097 Listeners
The Weekly Show with Jon Stewart
10,903 Listeners
Plain English with Derek Thompson
2,289 Listeners
Two Onc Docs
189 Listeners
At The Beam
37 Listeners